![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1244, 2000-01, pp. : 11-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Venlafaxine XR PREVENTs the recurrence of depression
Inpharma, Vol. 1, Iss. 1548, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Venlafaxine XR effective in anxiety disorders
Inpharma, Vol. 1, Iss. 1362, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Escitalopram cost effective vs venlafaxine XR in MDD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 473, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Escitalopram cost effective vs venlafaxine XR in MDD
Inpharma, Vol. 1, Iss. 1478, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Escitalopram: advantages over venlafaxine XR in depression
Inpharma, Vol. 1, Iss. 1414, 2003-01 ,pp. :